Waking
TYVASO DPI
The proven efficacy of TYVASO in the palm of your hand1,2
TYVASO DPI provides your patients with a simple-to-use treatment option for PH-ILD.1
TYVASO DPI efficiently leverages a low flow rate to deliver medication evenly.3,4
A strong breath is not required to deliver a consistent dose to the distal airways.4
- Powder dispersion occurs early in the onset of inhalation, helping to deliver the powder to the site of disease4
Treatment sessions can be scheduled around daily activities, approximately every 4 waking hours1:


Lunch

Dinner

Bedtime
How to Use TYVASO DPI
Taking a dose is as simple as:
JUST ONE BREATH—OPEN, LOAD, INHALE
Watch this video to see how simple it is to use TYVASO DPI.
DPI=dry powder inhaler.
TYVASO DPI®
THE PROVEN EFFICACY OF TYVASO® IN THE PALM OF YOUR HAND1,2
TYVASO DPI Inhalation Powder is a simple-to-use, inhaled prostacyclin therapy that delivers the trusted safety and benefits of TYVASO.1,2

Get the details about TYVASO DPI.
DPI=dry powder inhaler.
References: 1. TYVASO DPI [package insert]. Research Triangle Park, NC: United Therapeutics Corporation; 2022. 2. Spikes LA, Bajwa AA, Burger CD, et al. BREEZE: open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. Pulm Circ. 2022;12:e12063. doi:10.1002/pul2.12063.
This referral form has recently been revised to include TYVASO DPI™ (treprostinil) Inhalation Powder, a new dry powder inhaler option for your patients.
Currently, the 48 mcg (112 ct) and 64 mcg (112 ct) Maintenance Kits (28-day supply) are available for ordering. These strengths correspond with 8-10 breaths and 11-12 breaths with the TYVASO nebulizer, respectively. The remaining Maintenance Kits and Titration Kits will be available soon.
To learn more about TYVASO DPI and Kit availability, please reach out to your local United Therapeutics Cardiopulmonary Specialist.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.
YOU ARE NOW LEAVING THE TYVASO WEBSITE
This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASOhcp.com.